Verrica Parmaceuticals【VRCA】銘柄情報

Verrica Parmaceuticals Inc (VRCA) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

6.47

( -5.41% )

買値

6.40

売値

6.64

出来高

8,832

6.435 日の範囲 6.9299

0.5226 52 週間の範囲 9.8212

時価総額

111.147M

前日終値

6.84

始値

6.74

時刻

6.41

最終取引時間

00:13:00

財務取引量

US$ 59,708

VWAP

6.7605

平均取引量 (3 か月)

US$ 71,603

発行済株式数

17,178,786

配当利回り

PER

-5.22

1 株当たり利益 (EPS)

-1.31

歳入

37.16M

純利益

-17.83M

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation o... Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.verrica.com

本社

West Chester, United States

設立

2026

Verrica Parmaceuticals Inc is listed in the Healthcare sector of the ナスダック市場 with ticker VRCA. The last closing price for Verrica Parmaceuticals was US$6.84. Over the last year, Verrica Parmaceuticals shares have traded in a share price range of US$ 0.5226 to US$ 9.8212.

Verrica Parmaceuticals currently has 17,178,786 shares in issue. The market capitalisation of Verrica Parmaceuticals is US$111.15 million. Verrica Parmaceuticals has a price to earnings ratio (PE ratio) of -5.22.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.84	14.920071048	5.63	7	5.3	67986	6.16272731	CS
4	0.6	10.2214650767	5.87	7	5.3	44501	6.01498575	CS
12	0.97	17.6363636364	5.5	8.5	5.1	70642	6.59039133	CS
26	-1.52	-19.0237797247	7.99	9.02	4.245	110807	6.63160985	CS
52	5.94	1120.75471698	0.53	9.8212	0.5226	221533	4.71171265	CS
156	0.71	12.3263888889	5.76	11.41	0.3816	426546	3.71751824	CS
260	-5.36	-45.3085376162	11.83	14.789	0.3816	325753	4.05382718	CS